Clinical Trials Browser

Interventional × Hypergammaglobulinemia × Clear all

Acquired Immunodeficiency Syndrome, Diabetes Mellitus, Type 2, Hypergammaglobulinemia, Multiple Sclerosis, Neoplasms, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT03679624 2023-10-23

Daratumumab Plus Ibrutinib in Patients With Waldenstrӧm's Macroglobulinemia

Phase 2 Terminated

1 enrolled 8 charts

Lymphoid

Hypergammaglobulinemia, Waldenstrom Macroglobulinemia, Recurrence

Clinical Trials

EREVA

Daratumumab Plus Ibrutinib in Patients With Waldenstrӧm's Macroglobulinemia